SCHEMBL24169178

SCHEMBL24169178

CCn1c(SCC(=O)c2ccc(Br)cc2)nc2sc3c(c2c1=O)CCCC3

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.81
▸ ALDH1A1 P00352 3/20 0.69
▸ SMN1; SMN2 Q16637 2/20 0.69
▸ POLB P06746 6/20 0.68
▸ TDP1 Q9NUW8 5/20 0.68
▸ RECQL P46063 3/20 0.68
▸ NR4A1 P22736 2/20 0.68
▸ PTPN7 P35236 2/20 0.68
▸ APEX1 P27695 1/20 0.68
▸ APOBEC3A P31941 1/20 0.68
▸ APOBEC3G Q9HC16 1/20 0.68
▸ PDE4D Q08499 3/20 0.67
▸ TP53 P04637 1/20 0.67
▸ THRB P10828 1/20 0.66
▸ MAPT P10636 4/20 0.65
▸ L3MBTL1 Q9Y468 4/20 0.65
▸ HSD17B10 Q99714 2/20 0.65
▸ MEN1 O00255 2/20 0.65
▸ KMT2A Q03164 2/20 0.65
▸ CYP1A2 P05177 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079785 0.98 RXFP1 (0.78) RXFP1ALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079783 0.91 PDE4D (0.80) RXFP1ALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079784 0.89 POLB (0.71) RXFP1ALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079788 0.89 L3MBTL1 (0.77) RXFP1ALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079843 0.83 PDE4D (0.87) RXFP1ALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL13856555 0.81 POLB (1.00) ALDH1A1SMN1; SMN2POLBTDP1RECQL
SCHEMBL19088672 0.81 RXFP1 (0.85) RXFP1ALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079780 0.81 RXFP1 (0.67) RXFP1ALDH1A1SMN1; SMN2PDE4DTP53
SCHEMBL14478791 0.81 ALDH1A1 (0.77) ALDH1A1SMN1; SMN2POLBTDP1RECQL
SCHEMBL19079779 0.80 RXFP1 (0.84) RXFP1ALDH1A1SMN1; SMN2POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12472185-B2 Methods for killing antibiotic tolerant bacteria THE PENN STATE RESEARCH FOUNDATION (US) 2025-11-18 — — US claimed
US-20260041687-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA PENN STATE RES FOUND (US) 2026-02-12 — — US disclosed
US-12472185-B2 Methods for killing antibiotic tolerant bacteria THE PENN STATE RESEARCH FOUNDATION (US) 2025-11-18 — — US disclosed
US-20230201206-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA THE PENN STATE RESEARCH FOUNDATION 2023-06-29 — — US disclosed
US-20230201206-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA THE PENN STATE RESEARCH FOUNDATION 2023-06-29 — — US disclosed
US-20230201206-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA THE PENN STATE RESEARCH FOUNDATION 2023-06-29 — — US disclosed
US-11654146-B2 Methods for killing antibiotic tolerant bacteria THE PENN STATE RESEARCH FOUNDATION (US) 2023-05-23 — — US disclosed
US-11654146-B2 Methods for killing antibiotic tolerant bacteria THE PENN STATE RESEARCH FOUNDATION (US) 2023-05-23 — — US disclosed
US-11654146-B2 Methods for killing antibiotic tolerant bacteria THE PENN STATE RESEARCH FOUNDATION (US) 2023-05-23 — — US disclosed
US-20210401843-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA THE PENN STATE RESEARCH FOUNDATION 2021-12-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041687-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA VDAC1, VDAC3, VIL1 RXFP1 2629/4885ALDH1A1 534/4885SMN1; SMN2 1847/4885
US-11654146-B2 Methods for killing antibiotic tolerant bacteria CLPP, SPOUT1, CASP3 RXFP1 4086/4885ALDH1A1 942/4885SMN1; SMN2 3817/4885
US-20210401843-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA CLPP, SPOUT1, CASP3 RXFP1 4086/4885ALDH1A1 942/4885SMN1; SMN2 3817/4885
US-12472185-B2 Methods for killing antibiotic tolerant bacteria CLPP, SPOUT1, CASP3 RXFP1 4086/4885ALDH1A1 942/4885SMN1; SMN2 3817/4885
US-20230201206-A1 METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA CLPP, SPOUT1, CASP3 RXFP1 4086/4885ALDH1A1 942/4885SMN1; SMN2 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback